The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Open accessAbstract
BACKGROUND: Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the impact on outcomes of the type, number, and duration of drugs used to treat MDR-TB. METHODS AND FINDINGS: Three recent systematic reviews were used to identify studies reporting treatment outcomes of microbiologically confirmed MDR-TB. Study authors were contacted to solicit individual patient data including clinical characteristics, treatment given, and outcomes. Random effects multivariable logistic meta-regression was used to estimate adjusted odds of treatment success. Adequate treatment and outcome data were provided for 9,153 patients with MDR-TB from 32 observational studies. Treatment success, compared to failure/relapse, was associated with use of: later generation quinolones, (adjusted odds ratio [aOR]: 2.5 [95% CI 1.1-6.0]), ofloxacin (aOR: 2.5 [1.6-3.9]), ethionamide or prothionamide (aOR: 1.7 [1.3-2.3]), use of four or more likely effective drugs in the initial intensive phase (aOR: 2.3 [1.3-3.9]), and three or more likely effective drugs in the continuation phase (aOR: 2.7 [1.7-4.1]). Similar results were seen for the association of treatment success compared to failure/relapse or death: later generation quinolones, (aOR: 2.7 [1.7-4.3]), ofloxacin (aOR: 2.3 [1.3-3.8]), ethionamide or prothionamide (aOR: 1.7 [1.4-2.1]), use of four or more likely effective drugs in the initial intensive phase (aOR: 2.7 [1.9-3.9]), and three or more likely effective drugs in the continuation phase (aOR: 4.5 [3.4-6.0]). CONCLUSIONS: In this individual patient data meta-analysis of observational data, improved MDR-TB treatment success and survival were associated with use of certain fluoroquinolones, ethionamide, or prothionamide, and greater total number of effective drugs. However, randomized trials are urgently needed to optimize MDR-TB treatment. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model
Pinheiro, J. C., & Bates, D. M. (1995) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1995.10474663 · Cited by 1,188
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Van Deun, A., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 647
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Self-citationOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Self-citationEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Self-citationCommunity-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Self-citationTreatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Johnston, J. C., Shahidi, N. C., Sadatsafavi, M., & Fitzgerald, J. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006914 · Cited by 412
Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis
Mitnick, C. D., Shin, S. S., Seung, K. J., Rich, M. L., Atwood, S. S., Furin, J. J., Fitzmaurice, G. M., Alcantara Viru, F. A., Appleton, S. C., Bayona, J. N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800106 · Cited by 402
Self-citationFalzon, D., Jaramillo, E., & Schünemann, H. J. (2011) · European Respiratory Journal · doi:10.1183/13993003/erj.38.suppl_55.393 · Cited by 393
Self-citationTreatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336
Self-citationSpeaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
Laserson, K. F., Thorpe, L. E., Leimane, V., Weyer, K., Mitnick, C. D., Riekstiņa, V., Zarovska, E., Rich, M., Fraser, H., Alarcon, E., et al. (2005) · PubMed · Cited by 292
Self-citationLeimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Self-citationA multilevel model framework for meta-analysis of clinical trials with binary outcomes
Turner, R. M., Omar, R. Z., Yang, M., Goldstein, H., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3417::aid-sim614>3.0.co;2-l · Cited by 265
Yew, W. W., Chan, C. K., Chau, C. H., Tam, C. M., Leung, C. C., Wong, P. C., & Lee, J. (2000) · Chest · doi:10.1378/chest.117.3.744 · Cited by 231
Self-citationIseman, M. D., Madsen, L., Goble, M., & Pomerantz, M. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.623 · Cited by 162
Self-citationPsaty, B. M., & Siscovick, D. S. (2010) · JAMA · doi:10.1001/jama.2010.1205 · Cited by 159
Tupasi, T. E., Gupta, R., Quelapio, M. I. D., Orillaza-Chi, R., Mira, N. R. C., Mangubat, N. V., Belen, V., Arnisto, N., Macalintal, L., Arabit, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030352 · Cited by 123
Self-citationOutcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study
Chiang, C.-Y., Enarson, D. A., Yu, M.-C., Bai, K.-J., Huang, R.-M., Hsu, C.-J., Suo, J., & Lin, T.-P. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00125705 · Cited by 117
Self-citationMultilevel models for meta-analysis, and their application to absolute risk differences
Thompson, S. G., Turner, R., & Warn, D. E. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000602 · Cited by 113
Cox, H. S., Kalon, S., Allamuratova, S., Sizaire, V., Nikolaevna, T. Z., Rüsch–Gerdes, S., Karimovich, H. A., Kebede, Y. N., & Mills, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001126 · Cited by 108
Self-citationHoltz, T. H., Lancaster, J., Laserson, K. F., Wells, C. D., Thorpe, L. E., & Weyer, K. (2006) · PubMed · Cited by 101
Self-citationCulture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome
Schaaf, H. S. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.12.1106 · Cited by 99
Self-citationTreatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin, S., Pasechnikov, A., Gelmanova, I. Y., Gg, P., Strelis, A. K., Mishustin, S. P., Barnashov, A., Karpeichik, Y., Andreev, Y. G., Vt, G., et al. (2006) · PubMed · Cited by 91
Self-citationDoes DOTS work in populations with drug-resistant tuberculosis?
DeRiemer, K., García‐García, L., Bobadilla-del-Valle, M., Palacios-Martínez, M., Martínez‐Gamboa, A., Small, P. M., Sifuentes‐Osornio, J., & Ponce‐de‐León, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74812-1 · Cited by 90
Self-citationSelf-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Park, S. K., Lee, C. W., Lee, D. H., Mitnick, C. D., Han, L. L., & Seung, K. J. (2004) · PubMed · Cited by 76
Self-citationMultidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich, R. (2005) · JAMA · doi:10.1001/jama.293.22.2732 · Cited by 75
Self-citationRandomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis
Mitnick, C. D., Castro, K. G., Harrington, M., Sacks, L. V., & Burman, W. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040292 · Cited by 71
Self-citationQuy, H. T., Cobelens, F. G. J., Lan, N. T. N., Buu, T. N., Weezenbeek, C. S. B. L.-V., & Borgdorff, M. W. (2006) · PubMed · Cited by 71
Migliori, G. B., Espinal, M., Danilova, I. D., Пунга, В. В., Grzemska, M., & Raviglione, M. C. (2002) · PubMed · Cited by 70
Self-citationO'Riordan, P., Schwab, U., Logan, S. A. E., Cooke, G., Wilkinson, R. J., Davidson, R. N., Bassett, P., Wall, R. A., Pasvol, G., & Flanagan, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003173 · Cited by 66
Self-citationPalmero, D., Ambroggi, M., Brea, A., De Lucas, M., Fulgenzi, A., Martínez, D., Mosca, C., Musella, R. M., Natiello, M., González, C. D., et al. (2004) · PubMed · Cited by 62
Self-citationTreatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994–1997
Narita, M., Alonso, P. L., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., & Ashkin, D. (2001) · CHEST Journal · doi:10.1378/chest.120.2.343 · Cited by 58
Self-citationReviews of Individual Patient Data
Stewart, L. A., Tierney, J. F., & Clarke, M. J. (2008) · Wiley eBooks · doi:10.1002/9780470712184.ch18 · Cited by 57
Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
Masjedi, M. R., Tabarsi, P., Chitsaz, E., Baghaei, P., Mirsaeidi, M. S., Amiri, M., Farnia, P., Javanmard, P., Mansouri, D., & Velayati, A. A. (2008) · PubMed · Cited by 53
Self-citationLockman, S., Krüüner, A., BINKIN, N. J., Levina, K., Wang, Y., Danilovitš, M., Hoffner, S. E., & Tappero, J. W. (2001) · Clinical Infectious Diseases · doi:10.1086/318489 · Cited by 46
Use of Therapeutic Drug Monitoring for Multidrug-Resistant Tuberculosis Patients
Li, J., Burzynski, J. N., Lee, Y.-A., Berg, D. E., Driver, C. R., Ridzon, R., & Munsiff, S. S. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1770 · Cited by 39
Self-citationMultidrug-Resistant Tuberculosis: Long Term Follow-Up of 40 Non-HIV-Infected Patients
Avendaño, M. A., & Rs, G. (2000) · Canadian Respiratory Journal · doi:10.1155/2000/457905 · Cited by 35
A multilevel model framework for meta‐analysis of clinical trials with binary outcomes
Turner, R., Omar, R., Yang, M., Goldstein, H., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3417::aid-sim614>3.3.co;2-c · Cited by 24
Akçakir, Y. (2010) · eScholarship@McGill (McGill) · doi:10.82308/22209 · Cited by 22
Cited by
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
“These recommendations are supported by a large meta-analysis of individual data from more than 9000 patients (Ahuja et al. 2012).”
MethodSelf-citationTowards tuberculosis elimination: an action framework for low-incidence countries
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., Douglas, P., Falzon, D., Gaudreau, M.-A., Goletti, D., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00214014 · Cited by 778
Self-citationMultidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
Diacon, A. H., Pym, A., Grobusch, M. P., de los Rios, J. M., Gotuzzo, E., Vasilyeva, I., Leimane, V., Andries, K., Bakare, N., De Marez, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313865 · Cited by 746
Self-citationZumla, A., Raviglione, M., Hafner, R., & Fordham von Reyn, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1200894 · Cited by 698
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citation
Metadata
- Authors
- Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., Chan, E. D., Chiang, C.-Y., Cox, H., D'Ambrosio, L., DeRiemer, K., Dung, N. H., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Garcia-Garcia, M. L., Gandhi, N., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Iseman, M. D., Jarlsberg, L. G., Keshavjee, S., Kim, H.-R., Koh, W.-J., Lancaster, J., Lange, C., de Lange, W. C. M., Leimane, V., Leung, C. C., Li, J., Menzies, D., Migliori, G. B., Mishustin, S. P., Mitnick, C. D., Narita, M., O'Riordan, P., Pai, M., Palmero, D., Park, S.-K., Pasvol, G., Peña, J., Pérez-Guzmán, C., Quelapio, M. I. D., Ponce-de-Leon, A., Riekstina, V., Robert, J., Royce, S., Schaaf, H. S., Seung, K. J., Shah, L., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Tabarsi, P., Tupasi, T. E., van Altena, R., Van der Walt, M., Van der Werf, T. S., Vargas, M. H., Viiklepp, P., Westenhouse, J., Yew, W. W., Yim, J.-J., & Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-28
- Volume
- 9
- Issue
- 8
- Pages
- e1001300
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2168509294
- Cited by
- 535
- References
- 40
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.